Gotham Asset Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,148
| Closed | -$90.3K | – | 1529 |
|
|
2024
Q2 | $90.3K | Buy |
+10,148
| New | +$90.3K | ﹤0.01% | 1385 |
|
|
2023
Q2 | – | Sell |
-24,453
| Closed | -$569K | – | 1435 |
|
|
2023
Q1 | $569K | Sell |
24,453
-23,257
| -49% | -$541K | 0.01% | 915 |
|
|
2022
Q4 | $1.21M | Sell |
47,710
-24,474
| -34% | -$619K | 0.03% | 615 |
|
|
2022
Q3 | $1.39M | Buy |
72,184
+1,221
| +2% | +$23.5K | 0.04% | 533 |
|
|
2022
Q2 | $1.81M | Buy |
+70,963
| New | +$1.81M | 0.06% | 403 |
|
|
2022
Q1 | – | Sell |
-10,015
| Closed | -$419K | – | 1249 |
|
|
2021
Q4 | $419K | Buy |
10,015
+3,088
| +45% | +$129K | 0.01% | 834 |
|
|
2021
Q3 | $301K | Buy |
+6,927
| New | +$301K | 0.01% | 829 |
|